585 related articles for article (PubMed ID: 25099447)
1. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
4. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
5. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
6. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
[TBL] [Abstract][Full Text] [Related]
7. Biliary tract cancer.
Curley SA
Cancer Treat Res; 1997; 90():273-307. PubMed ID: 9367089
[No Abstract] [Full Text] [Related]
8. [Tumor grading of the hepatobiliary system].
Jütte H; Tannapfel A
Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
[TBL] [Abstract][Full Text] [Related]
9. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Benson AB; D'Angelica MI; Abrams T; Abbott DE; Ahmed A; Anaya DA; Anders R; Are C; Bachini M; Binder D; Borad M; Bowlus C; Brown D; Burgoyne A; Castellanos J; Chahal P; Cloyd J; Covey AM; Glazer ES; Hawkins WG; Iyer R; Jacob R; Jennings L; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Ronnekleiv-Kelly S; Sahai V; Singh G; Stein S; Turk A; Vauthey JN; Venook AP; Yopp A; McMillian N; Schonfeld R; Hochstetler C
J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
[TBL] [Abstract][Full Text] [Related]
11. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
Floreani A; Lisiero M; Baldovin T; Baldo V
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].
Ka I; Faye M; Diop PS; Faye ABNAC; Ndoye JM; Fall B
Pan Afr Med J; 2018; 29():13. PubMed ID: 29662598
[TBL] [Abstract][Full Text] [Related]
15. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Surrey LF; Frank R; Zhang PJ; Furth EE
Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
[TBL] [Abstract][Full Text] [Related]
16. [Surgery of hepatobiliary tumors].
Bork U; Koch M; Büchler MW; Weitz J
Chirurg; 2010 Feb; 81(2):111-16. PubMed ID: 20076936
[TBL] [Abstract][Full Text] [Related]
17. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic Cholangiocarcinoma.
El-Diwany R; Pawlik TM; Ejaz A
Surg Oncol Clin N Am; 2019 Oct; 28(4):587-599. PubMed ID: 31472907
[TBL] [Abstract][Full Text] [Related]
19. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
[TBL] [Abstract][Full Text] [Related]
20. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
